CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-21 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −1,100 | $18.18 | $20K | 1,625,466 |
| 2023-06-20 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −1,300 | $16.53 | $21K | 1,645,222 |
| 2023-06-16 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −3,316 | $16.49 | $55K | 1,697,960 |
| 2023-06-16 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −50,838 | $17.06 | $867K | 1,647,122 |
| 2023-06-16 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −600 | $18.50 | $11K | 1,646,522 |
| 2023-06-15 | Harris Todd Chief Executive Officer | Option exercise 10b5-1 | +12,773 | $2.25 | $29K | 1,714,049 |
| 2023-06-15 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −12,773 | $16.13 | $206K | 1,701,276 |
| 2023-06-15 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,773 | 376,837 | ||
| 2023-06-15 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +12,592 | $0.61 | $8K | 540,573 |
| 2023-06-15 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −12,592 | $16.15 | $203K | 527,981 |
| 2023-06-15 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,592 | 229,062 | ||
| 2023-06-14 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +120 | $0.61 | $73 | 528,101 |
| 2023-06-14 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −120 | $16.45 | $2K | 527,981 |
| 2023-06-14 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −120 | 241,654 | ||
| 2023-06-13 | Harris Todd Chief Executive Officer | Option exercise 10b5-1 | +7,927 | $2.25 | $18K | 1,709,203 |
| 2023-06-13 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −7,927 | $16.00 | $127K | 1,701,276 |
| 2023-06-13 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,927 | 389,610 | ||
| 2023-06-13 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +5,628 | $0.61 | $3K | 533,609 |
| 2023-06-13 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −5,628 | $16.01 | $90K | 527,981 |
| 2023-06-13 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,628 | 241,774 |
Page 12 of 21 · 417 trades